Related Experiment Video
Updated: Apr 11, 2026
08:26
Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
Published on: October 19, 2015
12.8K
Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challenges
Stuart I Jenkins1, Humphrey H P Yiu2, Matthew J Rosseinsky3
1Cellular and Neural Engineering Group, Institute for Science and Technology in Medicine Keele University, Stoke-on-Trent, Staffordshire ST5 5BG UK.
Molecular and Cellular Therapies
|June 10, 2015
Summary
Magnetic nanoparticles (MNPs) offer a promising solution for neural cell transplantation challenges. This review highlights MNPs
Area of Science:
- Neuroscience
- Biotechnology
- Materials Science
Background:
- Oligodendrocyte precursor cells (OPCs) show potential for central nervous system regeneration, particularly in myelin production.
- Key barriers to neural cell therapy translation include in vivo imaging, genetic engineering, and targeted delivery of transplant cells.
Purpose of the Study:
- To review the evidence for magnetic nanoparticles (MNPs) as a multifunctional nanoplatform for neural cell/OPC therapy.
- To address translational challenges in neural cell transplantation, including cell tracking, genetic modification, and targeted delivery.
Main Methods:
- Review of existing literature on the application of MNPs in neural cell transplantation.
- Analysis of MNP capabilities for in vivo cell biodistribution assessment (real-time and post-mortem).
- Evaluation of MNPs for biomolecule delivery and magnetic cell targeting to injury sites.
Main Results:
- MNPs can facilitate real-time and post-mortem assessment of transplant cell biodistribution.
- MNPs can be used for biomolecule delivery to transplant cells and magnetic cell targeting to injury sites.
Conclusions:
- MNPs represent a versatile nanoplatform with the potential to overcome major translational barriers in neural cell therapy.
- Standardization and reporting of MNP physicochemical and biological data are crucial for evaluating their utility and developing neurocompatible particles.
